BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10945950)

  • 1. Prolongation of rat islet xenograft survival in the liver of IFN-gamma-deficient mice.
    Maki T; Yasunami Y; Ikehara Y; Kodama S; Nakano M; Nakayama T; Taniguchi M; Ikeda S
    J Surg Res; 2000 Sep; 93(1):101-7. PubMed ID: 10945950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
    Toyofuku A; Yasunami Y; Nabeyama K; Nakano M; Satoh M; Matsuoka N; Ono J; Nakayama T; Taniguchi M; Tanaka M; Ikeda S
    Diabetes; 2006 Jan; 55(1):34-9. PubMed ID: 16380474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts.
    Kobayashi T; Harb G; Rajotte RV; Korbutt GS; Mallett AG; Arefanian H; Mok D; Rayat GR
    Xenotransplantation; 2006 Nov; 13(6):547-59. PubMed ID: 17059582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice.
    Ikehara Y; Yasunami Y; Kodama S; Maki T; Nakano M; Nakayama T; Taniguchi M; Ikeda S
    J Clin Invest; 2000 Jun; 105(12):1761-7. PubMed ID: 10862791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer.
    Yi S; Wang Y; Chandra AP; O'Hara JM; Wu J; Ouyang L; Burgess JS; Hawthorne W; Wu H; Chadban SJ; O'Connell PJ
    Transplantation; 2007 Mar; 83(5):615-23. PubMed ID: 17353783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
    Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
    Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation in the discordant tilapia-to-mouse model: a novel application of alginate microencapsulation in the study of xenograft rejection.
    Dickson BC; Yang H; Savelkoul HF; Rowden G; van Rooijen N; Wright JR
    Transplantation; 2003 Mar; 75(5):599-606. PubMed ID: 12640296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88-dependent toll-like receptor signalling is not a requirement for fetal islet xenograft rejection in mice.
    Schmidt P; Krook H; Goto M; Korsgren O
    Xenotransplantation; 2004 Jul; 11(4):347-52. PubMed ID: 15196129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy.
    Visser L; Poppema S; de Haan B; Klok P; van der Leij J; van den Berg A; de Vos P
    Transplantation; 2004 Feb; 77(3):386-91. PubMed ID: 14966412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type but not interferon-gamma-deficient T cells induce graft arterial disease in the absence of B cells.
    Furukawa Y; Cole SE; Shah RV; Fukumoto Y; Libby P; Mitchell RN
    Cardiovasc Res; 2004 Aug; 63(2):347-56. PubMed ID: 15249193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment.
    Ohtsuka K; Yasunami Y; Ikehara Y; Nagai T; Kodama S; Maki T; Tomita A; Abo T; Ikeda S
    Transplantation; 1997 Aug; 64(4):633-9. PubMed ID: 9293878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection.
    Singh NP; Guo L; Mhoyan A; Shirwan H
    Transplantation; 2003 Mar; 75(5):586-90. PubMed ID: 12640294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.